Vivani Medical, Inc. (VANI) stock
VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.14+0.05 (+4.59%)
Close on Nov 20, 2026Market cap $102.83MP/E –Yield –
Vivani Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Vivani Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$26.50M. For fiscal 2025 it was -$25.49M. The highest annual figure on record is -$11.52M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.49M | – |
| FY2024 | Dec 31, 2024 | -$21.34M | – |
| FY2023 | Dec 31, 2023 | -$24.59M | – |
| FY2022 | Dec 31, 2022 | -$19.13M | – |
| FY2021 | Dec 31, 2021 | -$11.52M | – |
| FY2020 | Dec 31, 2020 | -$17.15M | – |
| FY2019 | Dec 31, 2019 | -$28.12M | – |
| FY2018 | Dec 31, 2018 | -$29.97M | – |
| FY2017 | Dec 31, 2017 | -$24.21M | – |
| FY2016 | Dec 31, 2016 | -$25.56M | – |
| FY2015 | Dec 31, 2015 | -$21.31M | – |
| FY2014 | Dec 31, 2014 | -$17.65M | – |
| FY2013 | Dec 31, 2013 | -$17.67M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.99M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.17M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.16M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.11M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.84M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.69M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.77M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.00M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.09M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.54M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.21M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.99M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.49M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.69M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.76M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.19M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.75M | – |
| Q3 FY2018 | Sep 30, 2018 | -$7.48M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.89M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.85M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.80M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.71M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.02M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.69M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.10M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.06M | – |
See a number that looks wrong?